Join us for a webinar on September 14, 2026 at 2pm ET.

This educational program will provide an overview of HER2-positive gastric cancer, the role of biomarker testing in identifying eligible patients for targeted therapy, and emerging treatment advances that may help improve outcomes for those living with this disease.

Please note: This webinar is intended for educational and informational purposes only. It does not constitute medical advice, nor is it intended to recommend any specific treatment. Attendees should consult their healthcare providers regarding individual medical decisions.